Risk of heart failure hospitalization among users of dipeptidyl peptidase-4 inhibitors compared to glucagon-like peptide-1 receptor agonists
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Risk of heart failure hospitalization among users of dipeptidyl peptidase-4 inhibitors compared to glucagon-like peptide-1 receptor agonists
Authors
Keywords
Type 2 diabetes, DPP-4 inhibitors, GLP-1 agonists, Safety, Heart failure
Journal
Cardiovascular Diabetology
Volume 17, Issue 1, Pages -
Publisher
Springer Nature
Online
2018-07-17
DOI
10.1186/s12933-018-0746-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Association Between Use of Sodium-Glucose Cotransporter 2 Inhibitors, Glucagon-like Peptide 1 Agonists, and Dipeptidyl Peptidase 4 Inhibitors With All-Cause Mortality in Patients With Type 2 Diabetes
- (2018) Sean L. Zheng et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Comparative safety for cardiovascular outcomes of DPP-4 inhibitors versus glimepiride in patients with type 2 diabetes
- (2017) Hyouk-Jun Chin et al. MEDICINE
- Efficacy and safety of glucagon-like peptide-1 agonists on macrovascular and microvascular events in type 2 diabetes mellitus: A meta-analysis
- (2017) P. Gargiulo et al. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
- Risk for Hospitalized Heart Failure Among New Users of Saxagliptin, Sitagliptin, and Other Antihyperglycemic Drugs
- (2016) Sengwee Toh et al. ANNALS OF INTERNAL MEDICINE
- Glucagon-like peptide-1 receptor agonists and heart failure in type 2 diabetes: systematic review and meta-analysis of randomized and observational studies
- (2016) Ling Li et al. BMC Cardiovascular Disorders
- DPP-4 Inhibitors and Heart Failure: Some Reassurance, Some Uncertainty
- (2016) Kristian B. Filion et al. DIABETES CARE
- Association Between Hospitalization for Heart Failure and Dipeptidyl Peptidase 4 Inhibitors in Patients With Type 2 Diabetes: An Observational Study
- (2016) Alex Z. Fu et al. DIABETES CARE
- Dipeptidyl peptidase-4 inhibitors and risk of heart failure in type 2 diabetes: systematic review and meta-analysis of randomised and observational studies
- (2016) Ling Li et al. BMJ-British Medical Journal
- Dipeptidyl peptidase-4 inhibitors and risk of heart failure in type 2 diabetes: systematic review and meta-analysis of randomised and observational studies
- (2016) Ling Li et al. BMJ-British Medical Journal
- Teneligliptin improves left ventricular diastolic function and endothelial function in patients with diabetes
- (2015) Takehiro Hashikata et al. HEART AND VESSELS
- Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes
- (2015) Jennifer B. Green et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effect of vildagliptin, a dipeptidyl peptidase 4 inhibitor, on cardiac hypertrophy induced by chronic beta-adrenergic stimulation in rats
- (2014) Toru Miyoshi et al. Cardiovascular Diabetology
- GLP-1 receptor agonists vs. DPP-4 inhibitors for type 2 diabetes: is one approach more successful or preferable than the other?
- (2014) S. Brunton INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus
- (2013) Benjamin M. Scirica et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cardiovascular Biology of the Incretin System
- (2012) John R. Ussher et al. ENDOCRINE REVIEWS
- Mechanism of Action of DPP-4 Inhibitors—New Insights
- (2012) Adrian Vella JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- A protocol for active surveillance of acute myocardial infarction in association with the use of a new antidiabetic pharmaceutical agent
- (2012) Bruce Fireman et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- A systematic review of validated methods for identifying heart failure using administrative data
- (2012) Jane S. Saczynski et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now